Development and validation of a pre-chemotherapy nomogram integrating systemic immune-inflammation index and prognostic nutritional index to predict severe adjuvant toxicity in colorectal cancer

• by Wenjing Li, Hua Zhang, Jie Wu, Liyan Jin

• May 11, 2026

This Week’s Biopharma News: Amgen Deepens US Manufacturing Push

The company adds $300 million to its Puerto Rico biologics site as Pfizer reports Phase 3 myeloma data, J&J advances a dual-pathway IBD antibody, and BioNTech streamlines production

• May 12, 2026

• 7 min

The role of NAD+ metabolic reprogramming in colorectal cancer chemoresistance: mechanistic insights, clinical translation challenges and opportunities

• by Zhennan Ma, Xiuqing Gong, Fuquan Liu

• May 28, 2026

Editorial: Insights into gastrointestinal cancer metastasis from preclinical models

• by Bruna Costa, Alyssa Schledwitz, Jean-Pierre Raufman

• May 20, 2026